Advocacy in Action: International Patient Group Improves Hereditary Angioedema Diagnosis and Care Across the Asia–Pacific
Publication Date
1-1-2025
Document Type
Article
Publication Title
Clinical and Experimental Allergy
Abstract
This study demonstrates that patient advocacy groups significantly enhance medication availability and improve diagnosis of hereditary angioedema (HAE), particularly in emerging economies within the Asia-Pacific region. This study supports integrating patient advocacy group involvement into management guidelines, emphasising their role in improving access to diagnostics and treatment for HAE.
APA Citation
Wong, J., Tsui, C., Lao, K., Abong, J., Ali, A., Bhattarai, D., Hide, M., Jindal, A., Jordan, A., Kang, H., Katelaris, C., Suratannon, N., Tan, S., Lim, Y., Corcoran, D., Wardman, F., Boysen, H., Castaldo, A., & Li, P. (2025). Advocacy in Action: International Patient Group Improves Hereditary Angioedema Diagnosis and Care Across the Asia–Pacific. Faculty Research and Scholarly Works. Clinical and Experimental Allergy. https://doi.org/10.1111/cea.14623